Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

BUY
$96.34 - $112.38 $3,660 - $4,270
38 Added 1.88%
2,062 $206,000
Q1 2023

May 12, 2023

BUY
$107.32 - $113.5 $20,498 - $21,678
191 Added 10.42%
2,024 $221,000
Q4 2022

Jan 19, 2023

BUY
$62.39 - $113.8 $114,360 - $208,595
1,833 New
1,833 $209,000
Q2 2022

Jul 29, 2022

SELL
$79.4 - $116.36 $169,519 - $248,428
-2,135 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$86.42 - $109.81 $184,506 - $234,444
2,135 New
2,135 $225,000
Q4 2021

Jan 10, 2022

SELL
$98.56 - $119.91 $720,966 - $877,141
-7,315 Closed
0 $0
Q3 2021

Oct 21, 2021

BUY
$91.91 - $110.37 $672,321 - $807,356
7,315 New
7,315 $801,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.